Why nasolabial folds deepen, and what actually improves them
Calling the nasolabial fold a ‘wrinkle’ is inaccurate from the start. Anatomically it is a fixed boundary created by muscle attaching directly into the dermis, which is why it is present on young smiling faces too. What changes with age is not the line itself but the tissue draped over it. Once you know that difference, it becomes clear why some things work and others do not.
The conclusion, first
The nasolabial fold is not folded skin but a structure. Cadaveric histology confirmed that muscle fibres of the levator labii superioris group pass through the orbicularis oris and attach directly into the dermis, and this line disappears on a paralysed face and persists after death. It deepens with age not because the line is newly carved, but because the position of the line stays fixed by its muscular attachment while the fat above it atrophies and descends and the fibres joining skin to deep tissue lengthen. In three-dimensional measurement, nasolabial fold volume correlated with age at r = 0.727. On treatment, hyaluronic acid filler has the highest level of evidence (a network meta-analysis of 13 randomised trials), the common belief that “filling the cheek lifts the fold” was refuted by three-dimensional tracking, and thread lifting was found in a systematic review to have almost no evidence. This site also accounts for 13 to 15% of reports of filler-related blindness.
First — the nasolabial fold is not a wrinkle
In 1989 a study cut vertically through the nasolabial folds of four fresh cadavers and examined them histologically. This is what it established.
- Beneath the nasolabial fold there is dense fibrous tissue
- Muscle fibres of the levator labii superioris group pass through the orbicularis oris and attach directly into the dermis
- The nasolabial fold is absent on the face of a newborn, disappears on a paralysed face, and persists after death
Putting those three together gives a conclusion. The nasolabial fold is not a crease left by folded skin but a structural boundary formed along the points where muscle pulls on the dermis. It appears when muscle moves, and disappears when muscle stops.
Which muscle governs which part has also been established. The levator labii superioris alaeque nasi (LLSAN) defines the medial nasolabial fold and the levator labii superioris (LLS) the middle third. A 2017 study dissecting 12 hemifaces additionally reported a distinct muscle between the orbicularis oculi and the LLSAN, present in every specimen and attaching to the cheek fat.
So the accurate phrasing is not “a nasolabial fold has appeared” but “a boundary that was always there has come to look deeper”. This difference determines everything in the treatment discussion that follows.
So what does change — not the line, but the tissue above it
A 2023 study of 50 cadaveric heads explains this part in the most detail. Alongside sectioned specimens · histology · micro-CT, it also carried out mechanical tensile testing.
This is what it established.
- The fat compartments of the cheek take the nasolabial fold as their medial boundary. That is, the fat stops at that line
- The fibres joining skin to deep tissue (retinacula cutis) are arranged in a honeycomb pattern
- With age, the position of the nasolabial fold itself stays fixed by its muscular attachment while the fat above it atrophies and descends and the fibres lengthen, so that it comes to drape in a teardrop shape over a fixed boundary
The volume of the nasolabial fold has actually been measured. In a study using three-dimensional stereophotogrammetry on 87 normal volunteers (aged 13–84), nasolabial fold volume ranged from 0.0026 mL to 0.2306 mL, and the correlation with age was r = 0.727 (p < 0.0001). Men had larger volumes at all ages, and there was no left-right asymmetry.
In the same study, simply going from lying down to standing changed nasolabial fold volume significantly (p = 0.0012). In the mothers’ generation it increased by 32% on standing. There is a reason why looking in the mirror and taking a selfie lying down do not look the same.
The mechanism of deepening — what is established and what is disputed
| Mechanism | Evidence | Level |
|---|---|---|
| Descent · atrophy of midface fat | Cadaveric CT studies confirm inferior migration of the fat compartments, increased distance from the infraorbital rim, and volume loss of the deep medial cheek fat | Established |
| Maxillary resorption | Three-dimensional CT of 60 white subjects — the maxillary angle decreased significantly in both sexes. A study re-imaging 56 of the same individuals nine years apart also confirmed the decrease (p < 0.0001) | Established |
| Smoking | Comparison of 79 identical twin pairs — nasolabial folds significantly deeper in the smoking twin | Established |
| Ultraviolet exposure | 186 identical twin pairs — more sun exposure, older appearance (p = 0.015) | Established (not a nasolabial-fold-specific figure) |
| Repeated muscle contraction | In a twin study of 13 years of botulinum toxin, the nasolabial folds, which were not treated, aged equally in both twins | Points the other way, if anything |
| The proportional contribution of each mechanism | — | We could not find a quantitative comparison study |
The last row matters. We could not find a study apportioning contributions numerically, such as “fat atrophy 40%, bone resorption 30%”. If you see an article giving such numbers, it is worth checking its source.
And there is one point the field has not settled. Is it that the midface ‘descends’, or that it ‘deflates’? A 2007 study that scaled, aligned and superimposed old and current photographs of the same individuals found almost no inferior migration of upper midface landmarks and questioned the gravitational descent account. Cadaveric CT and the 50-head study above, on the other hand, support descent. Both exist.
Evidence by treatment — from strongest to weakest
| Treatment | Evidence | Assessment |
|---|---|---|
| Direct injection of hyaluronic acid filler | Network meta-analysis of 13 randomised trials. Double-blind split-face non-inferiority trial in Korean subjects (93 analysed, 48 weeks of follow-up) | Highest |
| PLLA (collagen-stimulating) injection | Randomised, evaluator-blinded trial of 233 subjects — superior to control from 3 to 13 months, effect persisting to 25 months | High |
| Radiofrequency | Single-arm cohort of 20 subjects — nasolabial laxity significantly improved at 12 weeks, maintained at 24 — no control group | Weak |
| Ultrasound (HIFU) | Systematic review of 16 studies · about 573 subjects — objective figures such as 0.47–1.7 mm of brow lift exist, but reporting on the nasolabial fold is limited. One study states that response at the brow was higher than at the nasolabial fold | Weak |
| Indirect improvement by restoring cheek (malar) volume | Three-dimensional tracking of 77 patients — no planar movement of nasolabial tissue was observed from malar injection alone | Negative |
| Thread lifting | Systematic review of 12 papers — “little or no substantial evidence supporting efficacy or safety has been added”. The two papers with positive results were manufacturer-funded | Very weak |
| Botulinum toxin | We could not find a randomised trial with the nasolabial fold as its primary endpoint | Could not verify |
| Skin boosters | The evidence for skin boosters concerns skin quality parameters; we could not verify a study with nasolabial fold depth as an endpoint | Could not verify |
On “filling the cheek lifts the fold”
This belief has actually been tested. 77 patients received 1–3 cc of hyaluronic acid above the malar eminence, and changes in the positions of their pores were tracked to measure three-dimensionally in what direction and how far the skin moved. The result, analysing the 37 whose expressions were consistent, was this.
Malar injection alone produced no planar movement of the tissue towards the nasolabial fold, and no traction on it. In the authors’ own terms, even 3 cc into the cheek left the skin between the injection site and the nasolabial fold unmoved. Improvement appeared when injection was made directly into the fold.
There is, however, a paper with the opposite result. A 2017 report described an additional positive effect on the nasolabial fold when the malar area was augmented with a particular hyaluronic acid volumiser, but we could not verify that paper’s design or sample size. Citing only one side would not be accurate, so we record both.
On thread lifting
The conclusion of the 2018 systematic review is worth quoting — that over ten years little or no substantial evidence supporting efficacy and safety had been added, that in all the literature except two papers the durability of the lifting effect was very limited at best, and that those two positive papers were funded by thread manufacturers.
The tensile testing in the 50-cadaver study above explains why. Even when sutures were placed deep in the cheek fat, tension was transmitted through the skin rather than through the fat layer. In other words, what ultimately takes the pulling force is the skin, which stretches easily.
The vascular problem at this site — written down, not hidden
It would be wrong to discuss nasolabial fold filler and leave this out. Article 56(2) of the Medical Service Act also prohibits advertising that omits important information such as adverse effects.
First the anatomy. In a 2024 study that contrast-imaged 52 Asian cadavers and reconstructed them three-dimensionally, the facial artery continued as the angular artery in 83.7%. In a 2025 ultrasound study of 45 Korean patients, 38% showed individual variation in the course of the facial artery.
So the explanation that “experience lets you avoid it” is not accurate. In more than one person in three, the vessel runs somewhere other than where the textbook says.
| Publication | Size | Distribution by site | Other |
|---|---|---|---|
| Global literature review (2015) | 98 cases | Glabella 38.8%, nose 25.5%, nasolabial fold 13.3%, forehead 12.2% | Autologous fat 47.9%, HA 23.5% |
| Updated review (2019) | 48 new cases · 146 cumulative | Nose 56.3%, glabella 27.1%, forehead 18.8%, nasolabial fold 14.6% (7 cases) | HA 81.3%. Most reports from Asia, with Korea the single largest at 17 cases. Complete blindness 52% |
| Korean Retina Society nationwide survey (2014) | 44 patients | — (the distribution by injection site is not in the abstract, so we could not verify it) | Autologous fat 22 · HA 13. The autologous fat group had a worse prognosis and a higher rate of accompanying cerebral infarction |
Do not pass over the figure of 81.3% HA in the second row. The statement that “hyaluronic acid is safe because it can be dissolved” concerns treatability, not frequency of occurrence. In the same review, complete blindness was 52%.
There are reports on the skin necrosis side as well. In a 2025 retrospective analysis of 12 patients who developed cutaneous ischaemia after nasolabial fold filler, 75% had an ischaemic pattern spanning the nasolabial fold and the whole nose.
Recommendations on injection plane have also been published. The Asian cadaver study above recommended the supraperiosteal plane for the upper third of the nasolabial fold and the dermal plane along the fold for the lower two-thirds. In the study of 45 Korean patients, the 20 injected under ultrasound guidance had zero vascular complications over 12 weeks.
The incidence is still unknown. We could not find statistics with a denominator such as “one case per so many syringes”. Everything available is based on case reports and case series. There is no basis for calling it either rare or common.
What you can do at home — what has evidence and what does not
| Measure | What we verified |
|---|---|
| Stopping smoking | Has evidence. In 79 identical twin pairs, the nasolabial folds of the smoking twin were significantly deeper. The changes were concentrated mainly in the middle and lower face |
| Sun protection | Has evidence, with a caveat. In a randomised trial of 903 subjects over 4.5 years, progression of skin ageing was 24% lower in the daily-use group (OR 0.76). But the site measured was the back of the hand, not the nasolabial fold |
| Facial exercises | No evidence for the nasolabial fold. In a trial of 32 facial exercises (16 completers), the only items among 20 that improved significantly were upper and lower cheek fullness, and the nasolabial fold was not among them. No control group |
| Massage · rollers | Indirect. In a randomised trial of 34 Korean women over 8 weeks, gross elasticity rose 8.6% in the roller group (p < 0.001). The nasolabial fold was not measured directly, and the authors themselves only inferred that it “would produce improvement in the long term” |
| Not sleeping on your side | No evidence. An observational study of sleep position and wrinkles (64 subjects) found no significant correlation. The 2016 paper often cited is a review, not an original study, and contains no controlled experimental data of its own |
One addition on posture: it is true that gravity changes nasolabial fold volume — in the study of 87 subjects above, volume changed significantly on going from lying to standing, increasing 32% in the mothers’ generation. But this is the immediate effect of “it shows less when you lie down”, not evidence for “sleeping on your side creates wrinkles”.
How we divide it up in the consulting room
A 2025 ultrasound study of 45 Korean patients classified the nasolabial fold into three types. It is not far from how we divide things in consultation, so we set it out here.
- Volume-deficient type — the tissue above has deflated, making the boundary relatively prominent
- Tissue-laxity type — the tissue above has come down and draped over it
- Muscular-traction type — strong muscular pull on expression is the main factor
This classification is a proposal, however, and not a study comparing treatment effects for each type in a randomised trial. In particular, using toxin for the muscular-traction type is offered as an option, but as written above we could not find a toxin trial with the nasolabial fold as its primary endpoint.
What we actually do is this — we look at how much it changes between sitting and lying, how the line moves on smiling, and whether the line becomes shallower when the tissue above is lifted by hand. The third check matters most. If the line stays as it is even when lifted by hand, that line is likely not one created by draped tissue but the part fixed by muscular attachment.
We also often make the judgement to do less. The nasolabial fold is not a line that can be eliminated entirely, and overfilling in an attempt to eliminate it makes the face deviate from its own expression when smiling. Setting the goal as ‘lightening the shadow’ rather than ‘removing it’ gives better results.
Adverse reactions to filler — Korean data
Apart from blindness, the frequency of everyday reactions has also been measured. These are the figures from a multicentre randomised double-blind split-face trial carried out in Korea (93 analysed, 48 weeks of follow-up).
| Item | Test group | Control group |
|---|---|---|
| Wrinkle severity rating scale at 24 weeks (WSRS) | 1.85 | 1.84 (non-inferiority met) |
| Rate of local adverse reactions | 92% | 82% (p = 0.0355) |
| Nature | Tenderness · pain · swelling · erythema — all resolving spontaneously within 2 weeks, zero serious adverse events | |
These numbers may surprise you. Most patients have some kind of reaction. But all of them disappeared within two weeks and none were serious. The statement that “there are almost no adverse effects” does not fit this data.
Duration also differs by product class. In the network meta-analysis of 13 randomised trials, the main assessment point for hyaluronic acid was 6 months, whereas PLLA was superior from 3 to 13 months with the effect persisting to 25 months. In the same analysis, hyaluronic acid had a significantly lower risk of nodule formation than bovine collagen (relative risk 0.593).
So generalising “filler lasts one to two years” to hyaluronic acid is inaccurate. The 13 to 25 months belongs to the PLLA data.
Summary — what we verified and what we could not
| Category | Detail |
|---|---|
| Verified | The nasolabial fold is a structure created by muscle attaching directly into the dermis and disappears on a paralysed face / with age the position of the line stays fixed while the tissue above changes / volume correlates with age at r = 0.727 / in smoking twins it is significantly deeper / hyaluronic acid filler has the highest evidence / malar injection alone does not move nasolabial tissue / thread lifting has almost no evidence in systematic review / this site accounts for 13 to 15% of reports of filler-related blindness, with most reports from Asia and Korea |
| Inferred | The account that early relapse after thread lifting is ‘because tension is transmitted through the skin’ — it follows from the cadaveric tensile testing, but is not a study linking it directly to clinical relapse rates |
| Could not verify | The proportional contribution of each ageing mechanism / an incidence with a denominator for vascular complications of nasolabial fold filler / official Korean tallies of filler adverse events / a botulinum toxin trial with the nasolabial fold as primary endpoint / a skin booster study with a nasolabial fold endpoint / the design and sample size of the 2017 report that malar volume restoration improved the nasolabial fold |
| Evidence pointing the other way | “Filling the cheek lifts the fold” was refuted by three-dimensional tracking / whether the midface ‘descends or deflates’ is still disputed in the field / the account that repeated expression is the cause conflicts with the twin botulinum toxin study / there is a study in which orthodontic retraction of the teeth actually improved the nasolabial fold (39 subjects, significant in those under 30) |
Reduced to a sentence: the nasolabial fold is not something to erase but a matter of sorting out the tissue draped over it, and the answer changes depending on which tissue is the problem. That is why we cannot give a single “for nasolabial folds, do this”.
Frequently asked questions
Why do young people have nasolabial folds too?
Because a nasolabial fold is not folded skin but a structure. A 1989 cadaveric histology study confirmed that muscle fibres of the levator labii superioris group pass through the orbicularis oris and attach directly into the dermis, and this line disappears on a paralysed face and persists after death. That is, it is a boundary formed along the points where muscle pulls on the dermis. The same study reported that the nasolabial fold is absent on the face of a newborn, however, so the phrase "it is there from birth" is not accurate.
Does the fold get newly carved as you age?
No. According to a 2023 study of 50 cadaveric heads, the position of the nasolabial fold itself stays fixed by its muscular attachment while the cheek fat above it atrophies and descends and comes to drape over that fixed boundary. In a study measuring 87 normal volunteers three-dimensionally, nasolabial fold volume correlated with age at r=0.727. That is, it is not that a new line appears but that a line that was always there comes to look deeper.
Does filler in the cheek lift the nasolabial fold?
In a three-dimensional tracking study it did not. When 77 patients received 1–3 cc of hyaluronic acid above the malar eminence and skin movement was measured by tracking changes in pore positions, malar injection alone produced no planar movement and no traction on the tissue towards the nasolabial fold. Improvement appeared when injection was made directly into the fold. There is also a 2017 report of an additional positive effect on the nasolabial fold with a particular hyaluronic acid volumiser, but we could not verify that paper's design or sample size, so we do not come down on either side.
Can thread lifting raise the nasolabial fold?
The evidence is very weak. A 2018 systematic review (12 papers) concluded that over the previous ten years little or no substantial evidence supporting the efficacy and safety of thread lifting had been added, and stated that in all the literature except two papers the durability of the effect was very limited at best and that those two positive papers were funded by thread manufacturers. Cadaveric tensile testing confirmed that even when sutures are placed deep in the cheek fat, tension is transmitted through the skin rather than the fat layer, which explains the mechanism of early relapse.
Does botulinum toxin improve the nasolabial fold?
We could not find a randomised trial with the nasolabial fold as its primary endpoint. The evidence for toxin injection into the levator labii superioris group is concentrated on the gummy smile indication. If anything, in a study comparing identical twins where one had received botulinum toxin regularly for 13 years, the nasolabial folds — an untreated site — aged equally in both twins. It is offered as an option for the type where muscular traction is the main factor, but that is a proposed classification, not a trial result. For reference, toxin at this site carries a risk of upper lip droop and asymmetry.
Is it true that nasolabial fold filler is dangerous?
The share this site holds in reports of filler-related blindness was 13.3% in a 2015 review (98 cases) and 14.6% in a 2019 updated review (146 cumulative cases). In the 2019 review 81.3% of the causative fillers were hyaluronic acid, most reports came from Asia, and Korea was the single largest source at 17 cases. Complete blindness was 52%. However, we could not find incidence statistics with a denominator, such as "one case per so many syringes". That means there is no basis for stating flatly that it is either rare or common.
Do most people swell or bruise after filler?
In a multicentre randomised double-blind split-face trial carried out in Korea (93 analysed), the rate of local adverse reactions was 92% in the test group and 82% in the control group. They were tenderness, pain, swelling and erythema, all resolved spontaneously within two weeks, and there were no serious adverse events. The numbers look high, but read them as meaning that most patients have a mild reaction and that it disappears within two weeks. The statement that "there are almost no adverse effects" does not fit this data.
How long does nasolabial fold filler last?
It depends on the product class. In the network meta-analysis of 13 randomised trials, the main assessment point for hyaluronic acid was 6 months, and the trial in Korean subjects followed up to 48 weeks. PLLA (the collagen-stimulating type) was superior to control from 3 to 13 months in a randomised trial of 233 subjects, with the effect persisting to 25 months. In other words the commonly quoted "one to two years" belongs to the PLLA data and is hard to generalise to hyaluronic acid.
Does sleeping on your side deepen the nasolabial fold?
We could not find evidence supporting this. An observational study of the correlation between sleep position and facial wrinkles (64 participants) found no significant correlation, and the 2016 paper often cited is a literature review rather than an original study, with no controlled experimental data of its own. It is true that posture immediately changes nasolabial fold volume, though — in the study of 87 subjects, volume changed significantly on going from lying to standing, increasing 32% in the mothers' generation. That is the effect of "it shows less when you lie down", not evidence for "sleeping on your side creates wrinkles".
Do facial exercises or massage help?
For the nasolabial fold there is no evidence. In a trial of 32 facial exercises carried out over 20 weeks (16 completers, no control group), the only two items among 20 that improved statistically significantly were upper and lower cheek fullness, and the nasolabial fold was not among them. In an 8-week randomised massage trial in 34 Korean women, gross elasticity rose 8.6% in the roller group (p<0.001), but the nasolabial fold was not measured directly and the authors merely inferred long-term improvement. What does have solid evidence is stopping smoking: in a comparison of 79 identical twin pairs, the nasolabial folds of the smoking twin were significantly deeper.
Who wrote this
Written and reviewed by Lee Chi-Hak, MD, medical director of Miso Clinic in Daegu, South Korea. Every study cited above is given together with its design, its size and the limitations the authors themselves recorded, and where we could not find data, we have said that we could not find any.
| Medical director | Lee Chi-Hak, MD |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea · Exit 1, Kyungpook National University Hospital Station |
| Phone | +82-53-428-2700 |
| Hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Columns | All clinical columns |
| Reference library | All booster and device references |
References
- The structure of the nasolabial fold was verified from Rubin LR et al., Plast Reconstr Surg 1989;83(1) (histology of 4 fresh cadavers — muscle fibres passing through the orbicularis oris to attach directly into the dermis, absent in newborns, disappearing on a paralysed face, persisting after death), Pessa JE · Brown F, Aesthetic Plast Surg 1992;16(2) (LLSAN = medial, LLS = middle third; sample size not stated in the abstract) and Snider CC et al., Aesthetic Plast Surg 2017;41(5) (12 hemifaces — malar levator identified in every specimen).
- The fat compartments and ageing mechanisms are Rohrich RJ · Pessa JE, Plast Reconstr Surg 2007;119(7) (30 cadaveric hemifaces — an anatomical paper, which did not measure the amount of atrophy), Minelli L · Mendelson BC et al., Aesthet Surg J 2023;43(9) (50 cadaveric heads, histology · micro-CT · mechanical tensile testing — the nasolabial fold position fixed, tension transmitted through the skin) and Gierloff M et al., Plast Reconstr Surg 2012;129(1) (cadaveric CT — inferior migration of the fat compartments; we could not verify the exact sample size).
- The volume measurements are See MS et al., Eur J Plast Surg 2007 (three-dimensional stereophotogrammetry, 87 normal volunteers aged 13–84 plus 15 mother-daughter pairs — volume 0.0026–0.2306 mL, correlation with age r = 0.7269, p < 0.0001, supine→upright change p = 0.0012, 32% increase in the mothers’ group). The skeletal data are Shaw RB Jr · Kahn DM, Plast Reconstr Surg 2007;119(2) (three-dimensional CT of 60 white subjects — significant decrease in the maxillary angle) and Fourgeot et al., Aesthet Surg J 2021;41(12) (CT twice in the same individuals, 56 subjects, mean interval over 7 years — angle p < 0.0001).
- The lifestyle factors are Okada HC et al., Plast Reconstr Surg 2013;132(5) (79 identical twin pairs discordant for smoking history — nasolabial folds significantly deeper in the smoking twin; the public abstract gives no p value), Guyuron B et al., Plast Reconstr Surg 2009;123(4) (186 twin pairs — sun exposure p = 0.015), Hughes MCB et al., Ann Intern Med 2013;158(11) (Australian randomised trial, 903 subjects · 4.5 years — 24% less progression of ageing, OR 0.76 [95% CI 0.59–0.98]; the site measured was the back of the hand, not the nasolabial fold) and Binder WJ, Arch Facial Plast Surg 2006;8(6) (2 identical twins, 13 years — the nasolabial folds, an untreated site, aged equally).
- The filler evidence is Li et al., Aesthetic Plast Surg 2024 (network meta-analysis of 13 randomised trials — HA > PLLA at 6 months, HA with nodule risk RR 0.593 [95% CI 0.438–0.803] against bovine collagen), Lee SH et al., Aesthet Surg J 2026;46(5) (Korean multicentre randomised · double-blind · split-face non-inferiority trial, 93 analysed, 48 weeks — WSRS at 24 weeks 1.85 against 1.84, local adverse reactions 92% against 82%, p = 0.0355, all resolving within 2 weeks) and Narins RS et al., JAAD 2010;62(3) (233 subjects, randomised · evaluator-blinded — PLLA superior from 3 to 13 months, effect persisting 25 months).
- The indirect effect of cheek volume is Mowlds DS · Lambros V, Plast Reconstr Surg 2018 (77 patients, 1–3 cc of HA to the malar area, skin movement vectors quantified by tracking pore positions, 37 with consistent expression analysed — no planar movement of nasolabial tissue and no traction). A report with the opposite result (Clin Cosmet Investig Dermatol 2017) exists, but we could not verify its design, sample size or figures. Thread lifting is Gülbitti HA et al., Plast Reconstr Surg 2018 (systematic review of 12 papers — almost no substantial evidence, the two positive papers manufacturer-funded).
- The device evidence is Contini M et al., IJERPH 2023;20(2):1522 (ultrasound, 16 papers · about 573 subjects — brow lift 0.47–1.7 mm, marionette line displacement 2.4–3.8%; one study states that response at the brow was higher than at the nasolabial fold) and Shin et al., Cosmetics 2024;11(3):71 (monopolar radiofrequency, 20 women mean age 47.95 — nasolabial laxity significantly improved at 12 weeks, maintained at 24; a single-arm cohort with no control group).
- The vascular anatomy and complications are Peng et al., Aesthetic Plast Surg 2024 (52 Asian cadavers, CTA three-dimensional reconstruction — 83.7% continuing as the angular artery, supraperiosteal plane recommended for the upper third and the dermal plane for the lower two-thirds), Hong et al., Aesthetic Plast Surg 2025 (45 Korean patients, ultrasound — variation in course in 38%, zero complications over 12 weeks in the 20 injected under ultrasound guidance) and Liao et al., Aesthetic Plast Surg 2025 (12 patients with cutaneous ischaemia — 75% with a nasolabial-plus-whole-nose pattern).
- The blindness statistics are Beleznay K et al., Dermatol Surg 2015 (98 cases — glabella 38.8%, nose 25.5%, nasolabial fold 13.3%; we could not obtain the original abstract directly, so this is secondary verification through a clinical guideline document), Beleznay K et al., Aesthet Surg J 2019;39(6) (48 new cases · 146 cumulative — nose 56.3%, glabella 27.1%, nasolabial fold 14.6% (7 cases), HA 81.3%, Korea the single largest at 17 cases, complete blindness 52%) and Park KH et al. (Korean Retina Society), JAMA Ophthalmol 2014;132(6) (survey of 27 retina centres nationwide, 44 patients — autologous fat 22 · HA 13, diffuse 28 · focal 16; the distribution by injection site is not in the abstract, so we could not verify it).
- The home measures are Alam M et al., JAMA Dermatol 2018;154(3) (pilot, 27 enrolled · 16 completers, no control group — of 20 items only upper and lower cheek fullness were significant, p = .003, estimated age 50.8→48.1 years; the nasolabial fold was not among the items that improved significantly) and Ahn SH et al., J Cosmet Dermatol 2025;24(6) (34 Korean women, randomised, 8 weeks — gross elasticity +8.6% in the roller group, p < 0.001; the nasolabial fold was not measured directly). The sleep position material is Anson G et al., Aesthet Surg J 2016;36(8) (a literature review, not an original study) and an observational study of 64 subjects (no significant correlation).
- What we recorded as “could not find” — the proportional contribution of each ageing mechanism; an incidence with a denominator for vascular complications of nasolabial fold filler; official MFDS or Korea Consumer Agency tallies of filler adverse events in Korea; a botulinum toxin trial with the nasolabial fold as primary endpoint; a skin booster study with a nasolabial fold endpoint.
- This article does not guarantee the effect of any particular treatment and does not compare or evaluate any particular medical institution. Indications and expected outcomes differ according to individual condition, and a consultation is required.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English · 日本語 · 简体中文 · Español · Tiếng Việt · ภาษาไทย · Bahasa Indonesia